A detailed history of Transatlantique Private Wealth LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Transatlantique Private Wealth LLC holds 19,396 shares of BMY stock, worth $1.04 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
19,396
Previous 24,520 20.9%
Holding current value
$1.04 Million
Previous $1.33 Million 39.43%
% of portfolio
0.33%
Previous 0.59%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $206,241 - $271,520
-5,124 Reduced 20.9%
19,396 $805,000
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $299,155 - $339,184
6,235 Added 34.1%
24,520 $1.33 Million
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $52,746 - $62,940
-1,088 Reduced 5.62%
18,285 $938,000
Q3 2023

Jun 25, 2024

SELL
$57.89 - $64.73 $297,959 - $333,165
-5,147 Reduced 20.99%
19,373 $1.12 Million
Q2 2023

Jun 25, 2024

BUY
$63.71 - $70.74 $47,527 - $52,772
746 Added 4.0%
19,373 $1.24 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $47,527 - $52,772
746 Added 4.0%
19,373 $1.24 Million
Q1 2023

Jun 25, 2024

SELL
$65.71 - $74.53 $387,229 - $439,205
-5,893 Reduced 24.03%
18,627 $1.29 Million
Q1 2023

May 05, 2023

BUY
$65.71 - $74.53 $109,407 - $124,092
1,665 Added 9.82%
18,627 $1.29 Million
Q4 2022

Jun 25, 2024

SELL
$68.48 - $81.09 $517,571 - $612,878
-7,558 Reduced 30.82%
16,962 $1.22 Million
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $4,451 - $5,270
65 Added 0.38%
16,962 $1.22 Million
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $322 - $190,486
2,479 Added 17.19%
16,897 $1.2 Million
Q2 2022

Aug 01, 2022

BUY
$72.62 - $79.98 $1.05 Million - $1.15 Million
14,418 New
14,418 $1.11 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $114B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Transatlantique Private Wealth LLC Portfolio

Follow Transatlantique Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transatlantique Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transatlantique Private Wealth LLC with notifications on news.